Churchill Capital Corp IX Ordinary Shares
NASDAQ:CCIXShell Companies
+$0.00 today
- Market cap
- $398.89M
- Beta
- -0.05
- P/E (TTM)
- 42.4
- EPS (TTM)
- $0.26
Volume 0.08M
Average 0.14M
CCIX Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Churchill Capital Corp IX Ordinary SharesNASDAQ: CCIX
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin grows, but more slowly than its trailing trend
Q1 FY2026 selling, general & admin of $1.15M rose 306.8% year over year, behind the +341.0% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 188.3% from the prior quarter.
Context
- Selling, general & admin increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly growth recovers from +306.8% toward the trailing-twelve-month pace of +341.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 3.94M USD
- Year-over-year change
- +374.0%
- 2-year CAGR
- +1341.3%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.94M | +374.0% |
| FY2024 | 2024-12-31 | 830.77K | +4282.2% |
| FY2023 | 2023-12-31 | 18.96K | — |
Selling, General & Admin vs competitors
How CCIX compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +341.0% is the 2nd highest of 9, against a peer median of +22.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.05B USD | +21609.2% | +1060.3% | 1727.7% | |
| LTM Mar 2026 | $250.18M USD | +10.2% | +6.6% | 37.9% | |
| LTM Apr 2026 | CA$68.97M CAD | +14.8% | +20.0% | 21.2% | |
| LTM Mar 2026 | $62.94M USD | +29.3% | +10.0% | 33.8% | |
| LTM Mar 2026 | $51.71M USD | +14.1% | +23.0% | 20.8% | |
| LTM Mar 2026 | $30M USD | +40.4% | +10.4% | 21.3% | |
CCIXChurchill Capital Corp IX Ordinary Shares | LTM Mar 2026 | $4.81M USD | +341.0% | — | — |
| LTM Mar 2026 | $1.11M USD | — | — | — | |
GPATGP-Act III Acquisition Corp. | LTM Mar 2026 | $917.15K USD | +30.0% | +161.6% | — |
| LTM Mar 2026 | $0 USD | -100.0% | — | — | |
| Peer median (excluding CCIX) | — | +22.0% | +20.0% | 27.6% | |
Competitors are the stored peer set for CCIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin | — | — | — |
| Research & Development | 0 | 0 | 0 |
| Selling, General & Admin | 18.96K | 830.77K | 3.94M |
| Operating Expenses | 18.96K | 830.77K | 3.94M |
| Depreciation & Amortization | 0 | 0 | 0 |
| EBITDA | (18.96K) | (830.77K) | (3.94M) |
| EBITDA Margin | — | — | — |
| Operating Income | (18.96K) | (830.77K) | (3.94M) |
| Operating Margin | — | — | — |
| Interest Income | 0 | 9.62M | 12.49M |
| Interest Expense | 0 | 0 | 0 |
| Other Income / Expenses | 0 | 9.62M | 12.49M |
| Income Before Tax | (18.96K) | 8.79M | 8.56M |
| Pre-Tax Margin | — | — | — |
| Income Tax Expense | 0 | 0 | 0 |
| Net Income | (18.96K) | 8.79M | 8.56M |
| Net Margin | — | — | — |
| EPS (Basic) | (0.00) | 0.34 | 0.23 |
| EPS (Diluted) | (0.00) | 0.33 | 0.23 |
| Weighted Avg Shares | 25.2M | 28.75M | 28.75M |
| Weighted Avg Shares (Diluted) | 25.2M | 28.75M | 28.75M |
Churchill Capital Corp IX Ordinary Shares
NASDAQ:CCIX
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.